000 01169 a2200313 4500
005 20250514011538.0
264 0 _c20011205
008 200112s 0 0 eng d
022 _a0169-5002
024 7 _a10.1016/s0169-5002(01)00311-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeppermann, K M
245 0 0 _aInfluence of age and comorbidities on the chemotherapeutic management of lung cancer.
_h[electronic resource]
260 _bLung cancer (Amsterdam, Netherlands)
_cSep 2001
300 _aS115-20 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCarcinoma, Small Cell
_xdrug therapy
650 0 4 _aComorbidity
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMiddle Aged
773 0 _tLung cancer (Amsterdam, Netherlands)
_gvol. 33 Suppl 1
_gp. S115-20
856 4 0 _uhttps://doi.org/10.1016/s0169-5002(01)00311-7
_zAvailable from publisher's website
999 _c11498327
_d11498327